Dunhill Financial’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.19K Buy
215
+36
+20% +$1.96K ﹤0.01% 599
2026
Q1
$11.3K Sell
179
-212
-54% -$17K ﹤0.01% 521
2025
Q4
$37.3K Buy
391
+16
+4% +$1.57K 0.01% 318
2025
Q3
$36.6K Buy
375
+1
+0.3% +$104 0.01% 290
2025
Q2
$40.2K Sell
374
-2
-0.5% -$202 0.01% 261
2025
Q1
$37.9K Sell
376
-23
-6% -$2.32K 0.02% 216
2024
Q4
$35.6K Buy
399
+71
+22% +$6.25K 0.02% 211
2024
Q3
$27.5K Buy
328
+152
+86% +$12K 0.01% 227
2024
Q2
$13.5K Buy
176
+28
+19% +$2.05K 0.01% 251
2024
Q1
$10.1K Buy
148
+16
+12% +$1.03K 0.01% 238
2023
Q4
$7.61K Buy
+132
New +$7.05K 0.01% 241

Other funds holding BSX

Dunhill Financial's BSX Position: Q2 2026 in Review

Dunhill Financial increased its Boston Scientific (BSX) stake by 20% in Q2 2026, buying an estimated $1.96K and bringing the position to 215 shares worth $9.19K. The position accounts for ﹤0.01% of the portfolio, ranked #599.

Dunhill Financial first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $40.2K in Q2 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Dunhill Financial held 215 shares of Boston Scientific worth $9.19K as of Q2 2026.
  • Dunhill Financial bought 36 Boston Scientific shares in Q2 2026, an estimated $1.96K.
  • Boston Scientific made up ﹤0.01% of Dunhill Financial's portfolio in Q2 2026, its #599 holding.
  • Dunhill Financial first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Dunhill Financial's Boston Scientific position peaked at $40.2K in Q2 2025.
  • 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.